This position contributes to the implementation of the global development strategy, leading or co-leading one or more clinical trials in a therapeutic area for one or more compounds in early clinical development. This may include clinical trial implementation, and oversight of all aspects of clinical development working closely with the Medical Director and other cross-functions to provide high-quality and timely deliverables.

Responsibilities

• Lead or co-lead one or more clinical trial(s) in a therapeutic area for one or more compounds
• Work closely with the Medical Director and other Clinical Research Scientists, as needed
• Contribute to the development of the program strategy for assigned trials/compounds and participate in the development of the clinical development plan
• Participate in the development and review of study plans, and serve as a liaison to project teams and CROs
• Give medical input for country/site selection, feasibility assessment and engage in key opinion leader interaction
• Chip in to training of investigators, sites and CRO/CRA, as warranted
• Contribute to the development of clinical and regulatory documents and registration dossiers i.e., protocol, ICF, IB, annual safety updates, study reports, regulatory submissions (briefing documents, IND, clinical dossiers) to support registration and commercialization of the compound(s) in collaboration with the Medical Director
• Participate in the development of case report forms and their completion guidelines, and provide scientific support for other key data management deliverables e.g. database lock activities
• Prepare charters, presentations and coordinate/participate in relevant committee meetings i.e., Dose Escalation, Data Monitoring and Safety Committees
• Lead the development of the medical data review plan, perform ongoing data review, and summarize efficacy and safety data for interpretation/analysis
• Provide input for the development of abstracts/publications in coordination with Scientific Communications

Requirements

• PhD, Pharm D, MS or equivalent degree preferably within the medical, biological, pharmaceutical science or related discipline
• Minimum of 6 years of experience in clinical research with at least 3 or more years of drug development experience
• Prior oncology/hematology drug development experience is a plus
• Proven skills from working in a project-oriented matrixed team environment
• Excellent oral, written and interpersonal (communication) skills
• Ability to travel, as needed

About You

• You are passionate about our purpose and genuinely care about our mission to transform the lives of patients through innovative cancer treatment
• You bring rigor and excellence to all that you do. You are a fierce believer in our rooted-in-science approach to problem-solving
• You are a generous collaborator who can work in teams with diverse backgrounds
• You are determined to do and be your best and take pride in enabling the best work of others on the team
• You are not afraid to grapple with the unknown and be innovative
• You have experience working in a fast-growing, dynamic company (or a strong desire to)
• You work hard and are not afraid to have a little fun while you do so

Locations

Genmab leverages the effectiveness of an agile working environment, when possible, for the betterment of employee work-life balance. Our offices are designed as open, community-based spaces that work to connect employees while being immersed in our state-of-the-art laboratories. Whether you’re in one of our collaboratively designed office spaces or working remotely, we thrive on connecting with each other to innovate.

About Genmab

Genmab is an international biotechnology company with a core purpose guiding its unstoppable team to strive towards improving the lives of patients through innovative and differentiated antibody therapeutics. For more than 20 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational research and data sciences, which has resulted in a proprietary pipeline including bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. To help develop and deliver novel antibody therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO™) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan.